Literature DB >> 31039022

The Evolution of MRI of the Prostate: The Past, the Present, and the Future.

Francesco Giganti1,2, Andrew B Rosenkrantz3, Geert Villeirs4, Valeria Panebianco5, Armando Stabile2,6, Mark Emberton2,7, Caroline M Moore2,7.   

Abstract

OBJECTIVE. The purpose of this article is to discuss the evolution of MRI in prostate cancer from the early 1980s to the current day, providing analysis of the key studies on this topic. CONCLUSION. The rapid diffusion of MRI technology has meant that residual variability remains between centers regarding the quality of acquisition and the quality and standardization of reporting.

Entities:  

Keywords:  MRI; consensus guidelines; history; prostatic neoplasms

Mesh：

Year:  2019        PMID： 31039022     DOI： 10.2214/AJR.18.20796

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


  8 in total

Review 1.  Is perfect the enemy of good? Weighing the evidence for biparametric MRI in prostate cancer.

Authors:  Alexander P Cole; Bjoern J Langbein; Francesco Giganti; Fiona M Fennessy; Clare M Tempany; Mark Emberton
Journal:  Br J Radiol       Date:  2021-12-16       Impact factor: 3.039

Review 2.  MR fingerprinting of the prostate.

Authors:  Wei-Ching Lo; Ananya Panda; Yun Jiang; James Ahad; Vikas Gulani; Nicole Seiberlich
Journal:  MAGMA       Date:  2022-04-13       Impact factor: 2.533

Review 3.  Imaging quality and prostate MR: it is time to improve.

Authors:  Francesco Giganti; Clare Allen
Journal:  Br J Radiol       Date:  2020-11-11       Impact factor: 3.039

4.  Risk factors associated with pain in fusion prostate biopsy.

Authors:  Gokhan Sonmez; Sevket T Tombul; Turev Demirtas; Abdullah Demirtas
Journal:  Prostate Int       Date:  2020-05-29

5.  Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.

Authors:  Armando Stabile; Francesco Giganti; Veeru Kasivisvanathan; Gianluca Giannarini; Caroline M Moore; Anwar R Padhani; Valeria Panebianco; Andrew B Rosenkrantz; Georg Salomon; Baris Turkbey; Geert Villeirs; Jelle O Barentsz
Journal:  Eur Urol Oncol       Date:  2020-03-17

6.  Development and validation of a multiparametric MRI-based radiomics signature for distinguishing between indolent and aggressive prostate cancer.

Authors:  Liuhui Zhang; Donggen Jiang; Chujie Chen; Xiangwei Yang; Hanqi Lei; Zhuang Kang; Hai Huang; Jun Pang
Journal:  Br J Radiol       Date:  2021-09-29       Impact factor: 3.039

7.  Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.

Authors:  Francesco Giganti; Eoin Dinneen; Veeru Kasivisvanathan; Aiman Haider; Alex Freeman; Alex Kirkham; Shonit Punwani; Mark Emberton; Greg Shaw; Caroline M Moore; Clare Allen
Journal:  Eur Radiol       Date:  2021-07-29       Impact factor: 5.315

Review 8.  Emerging methods for prostate cancer imaging: evaluating cancer structure and metabolic alterations more clearly.

Authors:  Adam Retter; Fiona Gong; Tom Syer; Saurabh Singh; Sola Adeleke; Shonit Punwani
Journal:  Mol Oncol       Date:  2021-08-30       Impact factor: 6.603
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.